Migraine: From Pathogenesis to Treatment
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (15 April 2024) | Viewed by 1013
Special Issue Editor
Special Issue Information
Dear Colleagues,
Awareness about the burden of migraine and its disability has grown. These factors have been increasingly recognized by migraine patients and researchers alike. In recent years, we have witnessed the development of new therapeutic options, but also an increase in the complexity of patients, with significantly more fragile and aged migraine patients, as well as patients with comorbidities and polydrug therapeutic regimens.
The new challenge in migraine research is to move towards better tailoring the available therapies and developing new safe treatments that could be implemented as stand-alone and add-on options. In order to achieve this, new statistical and machine learning models could be trained to differentiate among migraine subtypes and to predict responders by combining different data from different sources to better understand the mechanisms and outcomes associated. In parallel, a better classification of patients and responders to treatment could also help in developing newer and safer treatments targeted at specific patient subtypes in order to increase the chances of success and reduce the number of adverse events.
This Special Issue is focused on understanding and treating migraines, and aims to advance the current knowledge on migraine mechanisms to aid in the development of new therapeutic options: through pharmacological research; investigations on feasibility, tolerability, and efficacy, with a focus on host–drug mechanisms; and in combination with other technologies.
Dr. Alessandro Viganò
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- migraine
- tension type headache
- TDCS
- TMS
- RCT
